Calcium Dependence of Proteinase-activated Receptor 2 and Cholecystokinin-mediated Amylase Secretion from Pancreatic Acini
Overview
Physiology
Affiliations
Pancreatic acini secrete digestive enzymes in response to a variety of secretagogues including CCK and agonists acting via proteinase-activated receptor-2 (PAR2). We employed the CCK analog caerulein and the PAR2-activating peptide SLIGRL-NH(2) to compare and contrast Ca(2+) changes and amylase secretion triggered by CCK receptor and PAR2 stimulation. We found that secretion stimulated by both agonists is dependent on a rise in cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) and that this rise in [Ca(2+)](i) reflects both the release of Ca(2+) from intracellular stores and accelerated Ca(2+) influx. Both agonists, at low concentrations, elicit oscillatory [Ca(2+)](i) changes, and both trigger a peak plateau [Ca(2+)](i) change at high concentrations. Although the two agonists elicit similar rates of amylase secretion, the rise in [Ca(2+)](i) elicited by caerulein is greater than that elicited by SLIGRL-NH(2). In Ca(2+)-free medium, the rise in [Ca(2+)](i) elicited by SLIGRL-NH(2) is prevented by the prior addition of a supramaximally stimulating concentration of caerulein, but the reverse is not true; the rise elicited by caerulein is neither prevented nor reduced by prior addition of SLIGRL-NH(2). Both the oscillatory and the peak plateau [Ca(2+)](i) changes that follow PAR2 stimulation are prevented by the phospholipase C (PLC) inhibitor U73122, but U73122 prevents only the oscillatory [Ca(2+)](i) changes triggered by caerulein. We conclude that 1) both PAR2 and CCK stimulation trigger amylase secretion that is dependent on a rise in [Ca(2+)](i) and that [Ca(2+)](i) rise reflects release of calcium from intracellular stores as well as accelerated influx of extracellular calcium; 2) PLC mediates both the oscillatory and the peak plateau rise in [Ca(2+)](i) elicited by PAR2 but only the oscillatory rise in [Ca(2+)](i) elicited by CCK stimulation; and 3) the rate of amylase secretion elicited by agonists acting via different types of receptors may not correlate with the magnitude of the [Ca(2+)](i) rise triggered by those different types of secretagogue.
Low-Dose Trypsin Accelerates Wound Healing Protease-Activated Receptor 2.
Xiang Y, Jiang Y, Lu L ACS Pharmacol Transl Sci. 2024; 7(1):274-284.
PMID: 38230283 PMC: 10789143. DOI: 10.1021/acsptsci.3c00263.
Barreto S, Habtezion A, Gukovskaya A, Lugea A, Jeon C, Yadav D Gut. 2020; 70(1):194-203.
PMID: 32973069 PMC: 7816970. DOI: 10.1136/gutjnl-2020-322163.
Louhimo J, Steer M, Perides G Cell Mol Gastroenterol Hepatol. 2016; 2(4):519-535.
PMID: 27642624 PMC: 5020563. DOI: 10.1016/j.jcmgh.2016.04.002.
Bhatia V, Rastellini C, Han S, Aronson J, Greeley Jr G, Falzon M Am J Physiol Gastrointest Liver Physiol. 2014; 307(5):G533-49.
PMID: 25035110 PMC: 4154118. DOI: 10.1152/ajpgi.00428.2013.
Michael E, Kuliopulos A, Covic L, Steer M, Perides G Am J Physiol Gastrointest Liver Physiol. 2013; 304(5):G516-26.
PMID: 23275617 PMC: 3602677. DOI: 10.1152/ajpgi.00296.2012.